Ads
related to: nektar therapeutics stock price- Markets & Economy
View Our Latest Market Insights
and Get Economic Forecasts.
- PracticeLab®
Resources to Help You Build Your
Business and Engage Your Clients.
- Capital Ideas Webinars
Our Brightest Minds Answer
Your Questions.
- Equity Insights
View Our Latest Equity
Investment Insights.
- Market Volatility
Insights on Current Conditions from
Our Investment Professionals.
- Subscribe to Newsletter
Receive Our Latest Investment
Thinking In Your Inbox Each Week.
- Markets & Economy
invesco.com has been visited by 1M+ users in the past month
Search results
Nektar Therapeutics (NASDAQ:NKTR) is largely controlled by institutional shareholders who own 70% of...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Significantly high institutional ownership implies Nektar Therapeutics' stock price is...
Nektar Therapeutics (NASDAQ:NKTR shareholders incur further losses as stock declines 11% this week,...
Simply Wall St. via Yahoo Finance· 2 years agoWhile it may not be enough for some shareholders, we think it is good to see the Nektar Therapeutics...
Following a 75% decline over last year, recent gains may please Nektar Therapeutics (NASDAQ:NKTR)...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Given the large stake in the stock by institutions, Nektar Therapeutics' stock price...
Investors Don't See Light At End Of Nektar Therapeutics' (NASDAQ:NKTR) Tunnel
Simply Wall St. via Yahoo Finance· 12 months agoYou may think that with a price-to-sales (or "P/S") ratio of 1.3x Nektar Therapeutics (NASDAQ:NKTR)...
Zacks.com featured highlights include Disney, Casey's General Stores, OpGen, Accelerate Diagnostics...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – April 19, 2023 – Stocks in this week’s article are Disney DIS,...
Nektar Therapeutics (NKTR) Q2 Loss Narrows, Sales Miss
Zacks via Yahoo Finance· 10 months agoNektar Therapeutics NKTR reported a loss of 27 cents per share for the second quarter of 2023, which...
Nektar (NKTR) Upgraded to Buy: Here's Why
Zacks via Yahoo Finance· 1 year agoInvestors might want to bet on Nektar Therapeutics (NKTR), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a...
Nektar Therapeutics (NKTR) Incurs Wider-Than-Expected Q3 Loss
Zacks via Yahoo Finance· 7 months agoNektar Therapeutics NKTR reported an adjusted loss of 19 cents per share for the third quarter of...
Why Nektar Therapeutics Stock Is Plunging Today
Benzinga via Yahoo Finance· 1 year agoNektar Therapeutics (NASDAQ: NKTR) announced topline data from a Phase 2 study of rezpegaldesleukin (LY3471851 or REZPEG) in adults with...
Nektar Therapeutics (NASDAQ:NKTR) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoNektar Therapeutics (NASDAQ:NKTR) Q4 2023 Earnings Call Transcript March 4, 2024 Nektar Therapeutics...